$KSEZ
Kinetic Seas Inc.

2024 Q4 Form 10-Q Financial Statement

#000168316824008124 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $64.97K
YoY Change
Cost Of Revenue $52.49K
YoY Change
Gross Profit $12.48K
YoY Change
Gross Profit Margin 19.2%
Selling, General & Admin $134.1K
YoY Change 673.04%
% of Gross Profit 1074.73%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.056M
YoY Change 5987.46%
Operating Profit -$1.043M
YoY Change 5915.53%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$10.13K
YoY Change -5.21%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$1.054M
YoY Change 3658.94%
Net Earnings / Revenue -1621.65%
Basic Earnings Per Share -$0.06
Diluted Earnings Per Share -$0.06
COMMON SHARES
Basic Shares Outstanding 17.13M shares 16.74M shares
Diluted Shares Outstanding 16.86M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $13.97K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $20.82K
Other Receivables
Total Short-Term Assets $58.27K
YoY Change 1381.29%
LONG-TERM ASSETS
Property, Plant & Equipment $93.54K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $93.54K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $58.27K
Total Long-Term Assets $93.54K
Total Assets $151.8K
YoY Change 3758.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $102.7K
YoY Change 4569.14%
Accrued Expenses $33.49K
YoY Change 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $150.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $487.2K
YoY Change 115.46%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $487.2K
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$2.828M
YoY Change 176.5%
Common Stock $170.00
YoY Change 466.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$335.4K
YoY Change
Total Liabilities & Shareholders Equity $151.8K
YoY Change 3758.92%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$1.054M
YoY Change 3658.94%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56478
dei Entity Registrant Name
EntityRegistrantName
KINETIC SEAS INCORPORATED
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CO
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-1981170
dei Entity Address Address Line1
EntityAddressAddressLine1
1501 E. Woodfield Rd.
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Shell Company
EntityShellCompany
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 114E
dei Entity Address City Or Town
EntityAddressCityOrTown
Schaumburg
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60173
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
901-8806
dei Security12g Title
Security12gTitle
Common Stock
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17129000 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13969 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17931 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20816 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001945619
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2023Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2024Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
23489 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
58274 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
17931 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
93537 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13141 usd
CY2024Q3 us-gaap Assets
Assets
151810 usd
CY2023Q4 us-gaap Assets
Assets
31072 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
102721 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
0 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33486 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33486 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
4881 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
11098 usd
CY2024Q3 us-gaap Notes Payable
NotesPayable
150000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
0 usd
CY2024Q3 ECGR Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
196119 usd
CY2023Q4 ECGR Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
182000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
487207 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
226584 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17029000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17029000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26646000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26646000 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
170 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
266 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2492669 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
922020 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2828236 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1117798 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-335397 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-195512 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
151810 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31072 usd
CY2024Q3 us-gaap Revenues
Revenues
64966 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
137291 usd
us-gaap Revenues
Revenues
0 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
52490 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
106749 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
12476 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
30542 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
134083 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17345 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
479630 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
42277 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
787039 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
0 usd
us-gaap Professional Fees
ProfessionalFees
906571 usd
us-gaap Professional Fees
ProfessionalFees
0 usd
CY2024Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
119782 usd
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
0 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
261959 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
0 usd
CY2024Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
14967 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
0 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
63423 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
0 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
1055870 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
17345 usd
us-gaap Operating Expenses
OperatingExpenses
1711583 usd
us-gaap Operating Expenses
OperatingExpenses
42277 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1043394 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-17345 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1681041 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-42277 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
10125 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
10681 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
29397 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
23767 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10125 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10681 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-29397 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23767 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1053518 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-28027 usd
us-gaap Net Income Loss
NetIncomeLoss
-1710438 usd
us-gaap Net Income Loss
NetIncomeLoss
-66044 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16858576 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16858576 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3046000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3046000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23342109 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23342109 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3046000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3046000 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-156149 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-7322 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-163471 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-30695 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-194166 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-28027 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-222193 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-195512 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
250000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-199338 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-144850 usd
CY2024Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2000 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
205200 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-457582 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-395232 usd
CY2024Q3 ECGR Preferred Stock Issued For Financing Fee Value
PreferredStockIssuedForFinancingFeeValue
7500 usd
CY2024Q3 ECGR Common Stock Issued For Financing Fee Value
CommonStockIssuedForFinancingFeeValue
25000 usd
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
130850 usd
CY2024Q3 ECGR Preferred Stock Issued In Private Placement Value
PreferredStockIssuedInPrivatePlacementValue
200000 usd
CY2024Q3 ECGR Preferred Stock Issued For Services
PreferredStockIssuedForServices
750000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1053518 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-335397 usd
us-gaap Net Income Loss
NetIncomeLoss
-1710438 usd
us-gaap Net Income Loss
NetIncomeLoss
-66044 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19782 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
752000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
32499 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20816 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-0 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
23489 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
102725 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-10166 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
6217 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-23767 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-853954 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-52442 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
100178 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-100178 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
0 usd
us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
55000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
50000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
150000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
35881 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
-0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
786050 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
950169 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
55000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3962 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2558 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17931 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1376 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13969 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3934 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_843_eus-gaap--UseOfEstimates_zbjqKQp3H8S5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of accrued liabilities and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to revenue recognition, valuation of accounts receivable and the allowance for doubtful accounts, inventories, and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13969 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17931 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2828236 usd
CY2024Q3 ECGR Working Capital
WorkingCapital
-428934 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33486 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33486 usd
CY2024Q3 ECGR Notes Payable Related Party Current
NotesPayableRelatedPartyCurrent
146119 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
4606 usd
CY2024Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
23489 usd
us-gaap Debt Instrument Description
DebtInstrumentDescription
If the Company fails to pay the principal and accrued interest in full by the maturity date, the Company shall issue the Lender as a penalty payment, 100,000 restricted common shares.
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17029000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26646000 shares
CY2023Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
reverse split of 1 for 100
CY2024Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
150000 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-008124-index-headers.html Edgar Link pending
0001683168-24-008124-index.html Edgar Link pending
0001683168-24-008124.txt Edgar Link pending
0001683168-24-008124-xbrl.zip Edgar Link pending
ecgr-20240930.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kinetic_ex3101.htm Edgar Link pending
kinetic_ex3201.htm Edgar Link pending
kinetic_i10q-093024.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ecgr-20240930_cal.xml Edgar Link unprocessable
ecgr-20240930_def.xml Edgar Link unprocessable
ecgr-20240930_lab.xml Edgar Link unprocessable
ecgr-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
kinetic_i10q-093024_htm.xml Edgar Link completed